Patrick Leung, CTO of Faro, is leveraging AI to accelerate the traditionally slow and complex process of designing clinical trials in the pharmaceutical industry, aiming to save companies like Merck over $100 million per trial. AI enables Faro's team to prototype and iterate at unprecedented speeds, transforming laborious tasks typically conducted in Microsoft Word into efficient, AI-enhanced workflows. Despite the productivity gains, a new bottleneck has emerged in code review, prompting Faro to explore AI-assisted tools to maintain high standards of code quality. Faro's AI adoption extends beyond software development, with UX, QA, and DevOps teams automating various functions, allowing for broader operational efficiencies. Patrick emphasizes the importance of hiring engineers who are curious and adaptable, capable of integrating AI into their workflows, and believes that AI proficiency will be a crucial differentiator in the industry.